
Godavari Drugs Stock Hits 52-Week Low at Rs.69.7 Amidst Prolonged Downtrend
2025-12-09 11:23:32Godavari Drugs has reached a new 52-week low of Rs.69.7, marking a significant decline in its stock price amid a challenging market environment and subdued financial performance over the past year.
Read More
Godavari Drugs Stock Falls to 52-Week Low of Rs.70.31 Amidst Continued Downtrend
2025-12-08 11:00:57Godavari Drugs has reached a new 52-week low of Rs.70.31 today, marking a significant decline in its stock price amid ongoing downward momentum. The pharmaceutical company’s shares have been under pressure, reflecting a series of financial and market challenges over the past year.
Read More
Godavari Drugs Stock Falls to 52-Week Low of Rs.70.31 Amidst Prolonged Downtrend
2025-12-08 11:00:37Godavari Drugs has reached a new 52-week low of Rs.70.31, marking a significant decline in its stock price amid ongoing downward momentum. The pharmaceutical and biotechnology company’s shares have been under pressure, reflecting a series of financial and market challenges over the past year.
Read More
Godavari Drugs Stock Falls to 52-Week Low of Rs.70.31 Amidst Continued Downtrend
2025-12-08 11:00:21Godavari Drugs has reached a new 52-week low of Rs.70.31, marking a significant decline in its stock price amid ongoing downward momentum. The pharmaceutical company’s shares have been under pressure, reflecting a series of financial and market challenges over the past year.
Read More
Godavari Drugs Sees Revision in Market Evaluation Amidst Challenging Fundamentals
2025-12-07 10:10:03Godavari Drugs has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The pharmaceutical microcap’s recent assessment highlights a cautious stance driven by subdued sales growth, persistent negative earnings, and bearish trading patterns.
Read More
Godavari Drugs Falls to 52-Week Low of Rs.72.11 Amidst Prolonged Downtrend
2025-12-05 11:52:55Godavari Drugs has reached a new 52-week low of Rs.72.11, marking a significant decline in its stock price amid a challenging market environment and subdued financial performance over the past year.
Read More
Godavari Drugs Falls to 52-Week Low of Rs.73.2 Amidst Continued Downtrend
2025-12-02 09:26:41Godavari Drugs has reached a new 52-week low of Rs.73.2, marking a significant decline in its stock price amid a sustained downward trend over recent sessions. The pharmaceutical company’s shares have been under pressure, reflecting a series of financial and market factors that have influenced its performance.
Read More
Godavari Drugs Stock Hits 52-Week Low at Rs.74 Amidst Prolonged Downtrend
2025-12-01 11:19:32Godavari Drugs has reached a new 52-week low of Rs.74, marking a significant milestone in its ongoing price decline. The stock’s performance over the past year reflects a challenging period for the company within the Pharmaceuticals & Biotechnology sector.
Read More
Godavari Drugs Stock Falls to 52-Week Low of Rs.74 Amidst Prolonged Downtrend
2025-12-01 11:19:26Godavari Drugs has reached a new 52-week low of Rs.74, marking a significant milestone in its ongoing price decline. This development reflects a continuation of the stock’s subdued performance over the past year, contrasting with broader market gains.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
17-Nov-2025 | Source : BSENewspaper publication of Unaudited Financial Results for the quarter and half year ended September 30 2025
Unaudited Financials Results Pursuant To Regulation 33 Of The SEBI(LODR) Regulations 2015 For The Quarter And Half Year Ended 30Th September 2025
14-Nov-2025 | Source : BSEUnaudited Financial Statement for the Quarter and Half Year Ended 30th September 2025
Board Meeting Outcome for Unaudited Financial Statement For The Half-Year Ended 30Th September 2025
14-Nov-2025 | Source : BSEUnaudited Financial Statement For The Half-Year Ended 30Th September 2025
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






